Related references
Note: Only part of the references are listed.Insulin signalling in hepatocytes of humans with type 2 diabetes: excessive production and activity of protein kinase C-ι (PKC-ι) and dependent processes and reversal by PKC-ι inhibitors
M. P. Sajan et al.
DIABETOLOGIA (2012)
Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-i
Mini P. Sajan et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status
X. Stephenne et al.
DIABETOLOGIA (2011)
Metabolic functions of atypical protein kinase C: good and bad as defined by nutritional status
Robert V. Farese et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
AICAR and metformin, but not exercise, increase muscle glucose transport through AMPK-, ERK-, and PDK1-dependent activation of atypical PKC
M. P. Sajan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein
Ling He et al.
CELL (2009)
Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFκB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance
M. P. Sajan et al.
DIABETOLOGIA (2009)
The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFκB in obesity
Mini P. Sajan et al.
JOURNAL OF LIPID RESEARCH (2009)
The Irs1 Branch of the Insulin Signaling Cascade Plays a Dominant Role in Hepatic Nutrient Homeostasis
Shaodong Guo et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
PI3K activates negative and positive signals to regulate TRB3 expression in hepatic cells
Jixin Ding et al.
EXPERIMENTAL CELL RESEARCH (2008)
Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor foxo1 in liver
Michihiro Matsumoto et al.
CELL METABOLISM (2007)
Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects
V Luna et al.
DIABETOLOGIA (2006)
The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin
RJ Shaw et al.
SCIENCE (2005)
New insights into the integrated physiology of insulin action
Y Kitamura et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2004)
Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver -: Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states
ML Standaert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Tissue-specific differences in activation of atypical protein kinase C and protein kinase B in muscle, liver, and adipocytes of insulin receptor substrate-1 knockout mice
MP Sajan et al.
MOLECULAR ENDOCRINOLOGY (2004)
PKCλ in liver mediates insulin-induced SREBP-1c expression and determines both hepatic lipid content and overall insulin sensitivity
M Matsumoto et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes
N Musi et al.
DIABETES (2002)
Activation of the ERK pathway and atypical protein kinase C Isoforms in exercise- and aminoimidazole-4-carboxamide-1-β-D-riboside (AICAR)-stimulated glucose transport
HC Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
